. (ARIA)
$23.99 - (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
. (ARIA)
$23.99
- (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$23.99
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$23.99
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Cole Hugh M | SVP, Chief Business Officer | Jun 25, 2015 | Option Exercise | $8.69 | 6,249 | 54,304 | 42,834 | Feb 07, 2017, 04:59 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jan 31, 2017 | Option Exercise | $23.81 | 14,667 | 349,293 | 126,352 | Feb 02, 2017, 04:42 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jan 31, 2017 | Option Exercise | $23.82 | 9,610 | 228,886 | 219,867 | Feb 02, 2017, 04:41 PM |
Panayiotopoulos Paris | President and CEO | Jan 17, 2017 | Option Exercise | $23.69 | 33,300 | 788,934 | 159,378 | Jan 17, 2017, 05:06 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jan 09, 2017 | Option Exercise | $7.82 | 32,000 | 250,240 | 161,404 | Jan 10, 2017, 06:17 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jan 09, 2017 | Sale | $23.78 | 32,000 | 760,960 | 129,404 | Jan 10, 2017, 06:17 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Oct 24, 2016 | Sale | $9.56 | 19,638 | 187,739 | 197,884 | Oct 25, 2016, 04:07 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Oct 03, 2016 | Sale | $13.46 | 47,384 | 637,812 | 129,404 | Oct 05, 2016, 04:17 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Sep 28, 2016 | Sale | $13.98 | 8,750 | 122,311 | 217,522 | Sep 28, 2016, 04:19 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Sep 22, 2016 | Sale | $13.43 | 20,000 | 268,536 | 208,772 | Sep 23, 2016, 05:46 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Sep 15, 2016 | Option Exercise | $7.82 | 59,369 | 464,266 | 288,141 | Sep 16, 2016, 05:08 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Sep 15, 2016 | Sale | $11.73 | 59,369 | 696,398 | 228,772 | Sep 16, 2016, 05:08 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Aug 22, 2016 | Sale | $10.47 | 19,436 | 203,538 | 228,772 | Aug 23, 2016, 04:12 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Aug 12, 2016 | Option Exercise | $7.69 | 25,000 | 192,250 | 273,208 | Aug 15, 2016, 04:16 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Aug 12, 2016 | Sale | $10.50 | 25,000 | 262,500 | 248,208 | Aug 15, 2016, 04:16 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 22, 2016 | Sale | $8.11 | 18,286 | 148,230 | 248,208 | Jul 25, 2016, 04:39 PM |
Panayiotopoulos Paris | President and CEO | Jul 13, 2016 | Option Exercise | $7.14 | 28,611 | 204,283 | 126,078 | Jul 14, 2016, 04:23 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 01, 2016 | Option Exercise | $3.88 | 61,422 | 238,585 | 297,916 | Jul 05, 2016, 04:07 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 01, 2016 | Sale | $7.48 | 61,422 | 459,634 | 266,494 | Jul 05, 2016, 04:07 PM |
Cole Hugh M | SVP, Chief Business Officer | Jun 28, 2016 | Sale | $7.05 | 6,012 | 42,385 | 29,916 | Jun 29, 2016, 04:25 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jun 22, 2016 | Sale | $7.28 | 23,999 | 174,638 | 264,742 | Jun 23, 2016, 04:11 PM |
LAVIDAS ATHANESE | Director | Jun 15, 2016 | Option Exercise | $6.55 | 46,250 | 302,787 | 177,881 | Jun 15, 2016, 04:19 PM |
LAVIDAS ATHANESE | Director | Jun 14, 2016 | Option Exercise | $6.44 | 20,000 | 128,800 | 151,631 | Jun 15, 2016, 04:19 PM |
LAVIDAS ATHANESE | Director | Jun 13, 2016 | Option Exercise | $5.49 | 10,000 | 54,900 | 141,631 | Jun 15, 2016, 04:19 PM |
LAVIDAS ATHANESE | Director | Jun 15, 2016 | Sale | $8.24 | 46,250 | 381,137 | 131,631 | Jun 15, 2016, 04:19 PM |
LAVIDAS ATHANESE | Director | Jun 14, 2016 | Sale | $8.14 | 20,000 | 162,852 | 131,631 | Jun 15, 2016, 04:19 PM |
LAVIDAS ATHANESE | Director | Jun 13, 2016 | Sale | $8.20 | 10,000 | 82,050 | 131,631 | Jun 15, 2016, 04:19 PM |
Radaelli Massimo | Director | Jun 14, 2016 | Option Exercise | $4.91 | 6,250 | 30,687 | 111,750 | Jun 14, 2016, 06:13 PM |
Radaelli Massimo | Director | Jun 13, 2016 | Option Exercise | $6.57 | 79,731 | 523,551 | 185,231 | Jun 14, 2016, 06:13 PM |
Radaelli Massimo | Director | Jun 10, 2016 | Option Exercise | $1.35 | 22,588 | 30,494 | 128,088 | Jun 14, 2016, 06:13 PM |
Radaelli Massimo | Director | Jun 13, 2016 | Sale | $8.25 | 79,731 | 657,821 | 105,500 | Jun 14, 2016, 06:13 PM |
Radaelli Massimo | Director | Jun 10, 2016 | Sale | $8.30 | 22,588 | 187,480 | 105,500 | Jun 14, 2016, 06:13 PM |
Radaelli Massimo | Director | Jun 14, 2016 | Sale | $8.13 | 6,250 | 50,834 | 105,500 | Jun 14, 2016, 06:13 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | May 23, 2016 | Sale | $8.08 | 17,762 | 143,430 | 288,741 | May 25, 2016, 04:04 PM |
Panayiotopoulos Paris | President and CEO | May 12, 2016 | Buy | $7.41 | 26,990 | 199,996 | 88,089 | May 13, 2016, 05:59 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Apr 29, 2016 | Option Exercise | $7.18 | 5,634 | 40,452 | 158,711 | May 02, 2016, 05:33 PM |
Cantor Maria E | SVP, Corporate Affairs | Apr 29, 2016 | Option Exercise | $7.18 | 4,334 | 31,118 | 144,667 | May 02, 2016, 05:32 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Apr 29, 2016 | Option Exercise | $7.18 | 5,634 | 40,452 | 166,788 | May 02, 2016, 05:30 PM |
Cole Hugh M | SVP, Chief Business Officer | Apr 29, 2016 | Option Exercise | $7.18 | 5,634 | 40,452 | 16,762 | May 02, 2016, 05:29 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | May 02, 2016 | Sale | $7.13 | 11,700 | 83,478 | 306,503 | May 02, 2016, 05:28 PM |
Duvall Martin J | EVP, CCO | Apr 29, 2016 | Option Exercise | $7.18 | 5,850 | 42,003 | 105,189 | May 02, 2016, 05:26 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 22, 2016 | Sale | $7.37 | 21,409 | 157,864 | 294,803 | Apr 25, 2016, 04:04 PM |
DesRosier Thomas | EVP, General Counsel | Feb 18, 2016 | Option Exercise | $5.03 | 18,370 | 92,401 | 36,630 | Mar 30, 2016, 05:04 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 22, 2016 | Sale | $6.58 | 23,834 | 156,871 | 316,212 | Mar 23, 2016, 04:41 PM |
Duvall Martin J | EVP, CCO | Mar 19, 2016 | Sale | $6.47 | 4,000 | 25,867 | 93,039 | Mar 22, 2016, 04:03 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Mar 21, 2016 | Sale | $6.47 | 2,375 | 15,356 | 262,115 | Mar 22, 2016, 04:02 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 21, 2016 | Sale | $6.47 | 4,000 | 25,871 | 155,088 | Mar 22, 2016, 04:02 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 19, 2016 | Sale | $6.46 | 3,575 | 23,102 | 135,667 | Mar 22, 2016, 04:02 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 19, 2016 | Sale | $6.47 | 5,417 | 35,039 | 340,046 | Mar 22, 2016, 04:01 PM |
FITZGERALD EDWARD M | Executive VP | Mar 21, 2016 | Sale | $6.47 | 5,417 | 35,037 | 320,367 | Mar 22, 2016, 04:01 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 21, 2016 | Sale | $6.47 | 3,575 | 23,116 | 147,011 | Mar 22, 2016, 04:01 PM |
Cole Hugh M | SVP, Chief Business Officer | Mar 16, 2016 | Option Exercise | $6.21 | 2,438 | 15,140 | 5,062 | Mar 18, 2016, 04:04 PM |
Cole Hugh M | SVP, Chief Business Officer | Mar 16, 2016 | Option Exercise | $6.21 | 7,500 | 46,575 | 7,500 | Mar 18, 2016, 04:04 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 15, 2016 | Option Exercise | $6.18 | 22,814 | 141,009 | 132,024 | Mar 17, 2016, 04:45 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 15, 2016 | Option Exercise | $1.30 | 3,750 | 4,875 | 154,838 | Mar 17, 2016, 04:45 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 03, 2016 | Sale | $6.12 | 9,625 | 58,866 | 314,951 | Mar 03, 2016, 08:12 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Mar 03, 2016 | Sale | $6.12 | 9,625 | 58,887 | 259,740 | Mar 03, 2016, 08:08 PM |
Duvall Martin J | EVP, CCO | Mar 03, 2016 | Sale | $6.12 | 9,625 | 58,863 | 89,039 | Mar 03, 2016, 08:07 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 03, 2016 | Sale | $6.12 | 9,625 | 58,869 | 132,742 | Mar 03, 2016, 08:00 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 02, 2016 | Sale | $6.00 | 25,047 | 150,282 | 344,255 | Mar 03, 2016, 08:00 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 03, 2016 | Sale | $6.12 | 9,625 | 58,867 | 334,630 | Mar 03, 2016, 08:00 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 03, 2016 | Sale | $6.11 | 9,625 | 58,852 | 151,088 | Mar 03, 2016, 07:59 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 03, 2016 | Sale | $6.11 | 10,588 | 64,733 | 144,086 | Mar 03, 2016, 07:58 PM |
Panayiotopoulos Paris | President and CEO | Feb 01, 2016 | Buy | $4.91 | 61,099 | 299,996 | 61,099 | Feb 03, 2016, 05:43 PM |
Duvall Martin J | EVP, CCO | Feb 01, 2016 | Sale | $4.81 | 14,667 | 70,578 | 79,414 | Feb 03, 2016, 04:46 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 01, 2016 | Sale | $4.81 | 14,667 | 70,517 | 350,052 | Feb 03, 2016, 04:43 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Feb 01, 2016 | Sale | $4.81 | 14,667 | 70,548 | 141,463 | Feb 03, 2016, 04:41 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Feb 01, 2016 | Sale | $4.81 | 16,133 | 77,587 | 135,424 | Feb 03, 2016, 04:39 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Feb 01, 2016 | Sale | $4.81 | 14,667 | 70,515 | 250,115 | Feb 03, 2016, 04:38 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Feb 01, 2016 | Sale | $4.81 | 14,667 | 70,515 | 305,326 | Feb 03, 2016, 04:37 PM |
Cantor Maria E | SVP, Corporate Affairs | Feb 01, 2016 | Sale | $4.82 | 16,133 | 77,745 | 137,784 | Feb 03, 2016, 04:35 PM |
BERGER HARVEY J M D | Chairman & CEO | Dec 31, 2015 | Option Exercise | $6.25 | 284,381 | 1,777,381 | 1,732,111 | Jan 05, 2016, 05:41 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Sep 28, 2015 | Sale | $6.46 | 5,000 | 32,315 | 235,449 | Sep 30, 2015, 04:14 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 28, 2015 | Sale | $6.46 | 5,000 | 32,315 | 126,797 | Sep 28, 2015, 06:35 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 28, 2015 | Sale | $6.46 | 5,000 | 32,315 | 126,797 | Sep 28, 2015, 06:14 PM |
Duvall Martin J | EVP, CCO | Sep 28, 2015 | Sale | $6.46 | 5,000 | 32,317 | 64,748 | Sep 28, 2015, 06:09 PM |
Cantor Maria E | SVP, Corporate Affairs | Sep 28, 2015 | Sale | $6.47 | 5,000 | 32,327 | 109,917 | Sep 28, 2015, 05:57 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Sep 28, 2015 | Sale | $6.46 | 8,750 | 56,551 | 289,231 | Sep 28, 2015, 05:50 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Sep 28, 2015 | Sale | $6.45 | 5,500 | 35,502 | 122,224 | Sep 28, 2015, 05:40 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Sep 28, 2015 | Sale | $6.46 | 8,750 | 56,560 | 334,086 | Sep 28, 2015, 05:36 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Sep 28, 2015 | Sale | $6.46 | 5,000 | 32,315 | 240,449 | Sep 28, 2015, 05:02 PM |
Cantor Maria E | SVP, Corporate Affairs | Sep 01, 2015 | Sale | $9.11 | 2,696 | 24,557 | 104,917 | Sep 03, 2015, 04:20 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Aug 28, 2015 | Sale | $10.00 | 32,858 | 328,580 | 280,481 | Sep 01, 2015, 05:14 PM |
Cantor Maria E | SVP, Corporate Affairs | Aug 28, 2015 | Sale | $10.00 | 1,268 | 12,680 | 107,613 | Sep 01, 2015, 05:14 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 16, 2015 | Sale | $8.54 | 7,000 | 59,797 | 325,336 | Jul 16, 2015, 05:40 PM |
Duvall Martin J | EVP, CCO | Jul 16, 2015 | Sale | $8.54 | 1,400 | 11,956 | 59,748 | Jul 16, 2015, 05:34 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Jul 16, 2015 | Sale | $8.54 | 7,000 | 59,793 | 313,339 | Jul 16, 2015, 05:25 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jul 16, 2015 | Sale | $8.54 | 4,000 | 34,164 | 121,797 | Jul 16, 2015, 05:14 PM |
Cantor Maria E | SVP, Corporate Affairs | Jul 16, 2015 | Sale | $8.54 | 4,000 | 34,162 | 108,881 | Jul 16, 2015, 05:12 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Jul 16, 2015 | Sale | $8.54 | 4,000 | 34,162 | 230,449 | Jul 16, 2015, 05:10 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Jul 16, 2015 | Sale | $8.54 | 4,400 | 37,575 | 117,724 | Jul 16, 2015, 05:08 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 15, 2015 | Option Exercise | $8.35 | 17,370 | 145,040 | 1,366,492 | Jul 16, 2015, 04:22 PM |
FITZGERALD EDWARD M | Executive VP, CFO | May 01, 2015 | Option Exercise | $7.56 | 60,000 | 453,600 | 365,852 | May 04, 2015, 04:36 PM |
FITZGERALD EDWARD M | Executive VP, CFO | May 01, 2015 | Sale | $8.80 | 60,000 | 528,000 | 305,852 | May 04, 2015, 04:36 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 23, 2015 | Sale | $9.50 | 123,766 | 1,175,777 | 316,548 | Apr 27, 2015, 04:14 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 26, 2015 | Option Exercise | $8.17 | 127,194 | 1,039,175 | 1,343,460 | Mar 30, 2015, 04:21 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 26, 2015 | Option Exercise | $7.56 | 150,000 | 1,134,000 | 1,446,175 | Mar 30, 2015, 04:21 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Mar 23, 2015 | Sale | $8.56 | 2,000 | 17,118 | 226,449 | Mar 23, 2015, 06:26 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Mar 20, 2015 | Sale | $8.85 | 2,375 | 21,026 | 224,449 | Mar 23, 2015, 06:26 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Mar 19, 2015 | Option Exercise | $3.08 | 7,875 | 24,255 | 114,504 | Mar 23, 2015, 06:16 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Mar 23, 2015 | Sale | $8.55 | 4,033 | 34,491 | 104,881 | Mar 23, 2015, 06:16 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Mar 20, 2015 | Sale | $8.85 | 3,575 | 31,627 | 101,583 | Mar 23, 2015, 06:16 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Mar 19, 2015 | Sale | $9.00 | 9,346 | 84,114 | 106,629 | Mar 23, 2015, 06:16 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 23, 2015 | Sale | $8.55 | 3,000 | 25,661 | 117,797 | Mar 23, 2015, 06:06 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 20, 2015 | Sale | $8.85 | 4,000 | 35,390 | 114,797 | Mar 23, 2015, 06:06 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 23, 2015 | Sale | $8.55 | 4,167 | 35,630 | 305,209 | Mar 23, 2015, 06:02 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 20, 2015 | Sale | $8.84 | 5,417 | 47,908 | 301,043 | Mar 23, 2015, 06:02 PM |
Duvall Martin J | EVP, CCO | Mar 23, 2015 | Sale | $8.57 | 834 | 7,145 | 54,950 | Mar 23, 2015, 05:59 PM |
Duvall Martin J | EVP, CCO | Mar 20, 2015 | Sale | $8.85 | 4,000 | 35,381 | 54,117 | Mar 23, 2015, 05:59 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 23, 2015 | Sale | $8.55 | 3,300 | 28,229 | 114,124 | Mar 23, 2015, 05:54 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 20, 2015 | Sale | $8.85 | 3,575 | 31,634 | 111,424 | Mar 23, 2015, 05:54 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 19, 2015 | Option Exercise | $7.56 | 20,657 | 156,167 | 460,971 | Mar 23, 2015, 05:45 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 19, 2015 | Sale | $9.00 | 20,657 | 185,913 | 440,314 | Mar 23, 2015, 05:45 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 23, 2015 | Sale | $8.55 | 6,667 | 57,016 | 440,314 | Mar 23, 2015, 05:45 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 20, 2015 | Sale | $8.84 | 5,417 | 47,910 | 433,648 | Mar 23, 2015, 05:45 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Mar 23, 2015 | Sale | $8.56 | 2,000 | 17,118 | 159,907 | Mar 23, 2015, 05:27 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Mar 20, 2015 | Sale | $8.85 | 2,375 | 21,026 | 157,907 | Mar 23, 2015, 05:27 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 16, 2015 | Option Exercise | $1.30 | 7,500 | 9,750 | 145,222 | Mar 18, 2015, 04:23 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 16, 2015 | Sale | $8.62 | 34,425 | 296,651 | 137,722 | Mar 18, 2015, 04:23 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 20, 2015 | Option Exercise | $3.54 | 49,035 | 173,419 | 453,231 | Feb 24, 2015, 04:23 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 20, 2015 | Sale | $8.00 | 49,035 | 392,280 | 428,232 | Feb 24, 2015, 04:23 PM |
BERGER HARVEY J M D | Chairman & CEO | Feb 12, 2015 | Buy | $6.90 | 12,500 | 86,280 | 1,864,286 | Feb 13, 2015, 04:21 PM |
BERGER HARVEY J M D | Chairman & CEO | Feb 11, 2015 | Buy | $6.77 | 12,500 | 84,569 | 1,851,786 | Feb 13, 2015, 04:21 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Feb 02, 2015 | Sale | $6.33 | 16,134 | 102,107 | 108,499 | Feb 04, 2015, 04:52 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Feb 02, 2015 | Sale | $6.33 | 16,134 | 102,089 | 100,129 | Feb 04, 2015, 04:19 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Feb 02, 2015 | Sale | $6.33 | 14,667 | 92,823 | 137,722 | Feb 04, 2015, 04:18 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 02, 2015 | Sale | $6.33 | 14,667 | 92,820 | 428,232 | Feb 04, 2015, 04:17 PM |
Duvall Martin J | EVP, CCO | Feb 02, 2015 | Sale | $6.33 | 14,667 | 92,823 | 50,117 | Feb 04, 2015, 04:16 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Feb 02, 2015 | Sale | $6.33 | 14,667 | 92,849 | 295,627 | Feb 04, 2015, 04:16 PM |
BERSTEIN DAVID L | SVP, Chief IP Counsel | Feb 02, 2015 | Sale | $6.33 | 14,667 | 92,826 | 222,074 | Feb 04, 2015, 04:14 PM |
BERGER HARVEY J M D | Chairman & CEO | Jan 23, 2015 | Buy | $6.18 | 12,500 | 77,250 | 1,839,286 | Jan 26, 2015, 04:09 PM |
BERGER HARVEY J M D | Chairman & CEO | Jan 22, 2015 | Buy | $6.16 | 12,500 | 76,990 | 1,826,786 | Jan 26, 2015, 04:09 PM |
Schlesinger Sarah J. | Director | Jan 13, 2015 | Buy | $6.97 | 1,300 | 9,061 | 14,300 | Jan 15, 2015, 04:30 PM |
Schlesinger Sarah J. | Director | Jan 14, 2015 | Buy | $6.25 | 1,300 | 8,125 | 15,600 | Jan 15, 2015, 04:30 PM |
BERGER HARVEY J M D | Chairman & CEO | Dec 18, 2014 | Buy | $6.54 | 12,500 | 81,770 | 1,814,286 | Dec 19, 2014, 04:29 PM |
BERGER HARVEY J M D | Chairman & CEO | Dec 17, 2014 | Buy | $6.15 | 12,500 | 76,875 | 1,801,786 | Dec 19, 2014, 04:29 PM |
Schlesinger Sarah J. | Director | Dec 17, 2014 | Buy | $6.11 | 1,300 | 7,943 | 13,000 | Dec 18, 2014, 04:09 PM |
Schlesinger Sarah J. | Director | Dec 16, 2014 | Buy | $6.07 | 1,300 | 7,891 | 11,700 | Dec 18, 2014, 04:09 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Nov 24, 2014 | Sale | $7.00 | 1,749 | 12,243 | 86,929 | Nov 25, 2014, 04:22 PM |
BERGER HARVEY J M D | Chairman & CEO | Nov 20, 2014 | Buy | $6.15 | 12,500 | 76,889 | 1,789,286 | Nov 21, 2014, 04:18 PM |
BERGER HARVEY J M D | Chairman & CEO | Nov 19, 2014 | Buy | $6.15 | 12,500 | 76,853 | 1,776,786 | Nov 21, 2014, 04:18 PM |
Schlesinger Sarah J. | Director | Nov 12, 2014 | Buy | $6.22 | 1,300 | 8,086 | 10,400 | Nov 13, 2014, 04:27 PM |
Schlesinger Sarah J. | Director | Nov 11, 2014 | Buy | $6.30 | 1,300 | 8,190 | 9,100 | Nov 13, 2014, 04:27 PM |
BERGER HARVEY J M D | Chairman & CEO | Oct 16, 2014 | Buy | $5.39 | 12,500 | 67,317 | 1,764,286 | Oct 17, 2014, 04:24 PM |
BERGER HARVEY J M D | Chairman & CEO | Oct 15, 2014 | Buy | $5.10 | 12,500 | 63,727 | 1,751,786 | Oct 17, 2014, 04:24 PM |
Schlesinger Sarah J. | Director | Oct 15, 2014 | Buy | $5.03 | 1,300 | 6,539 | 7,800 | Oct 16, 2014, 04:27 PM |
Schlesinger Sarah J. | Director | Oct 14, 2014 | Buy | $5.07 | 1,300 | 6,591 | 6,500 | Oct 16, 2014, 04:27 PM |
BERGER HARVEY J M D | Chairman & CEO | Sep 03, 2014 | Buy | $6.31 | 12,500 | 78,859 | 1,739,286 | Sep 18, 2014, 04:30 PM |
BERGER HARVEY J M D | Chairman & CEO | Sep 02, 2014 | Buy | $6.22 | 12,500 | 77,777 | 1,726,786 | Sep 18, 2014, 04:30 PM |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | Sep 09, 2014 | Option Exercise | $5.75 | 7,118 | 40,929 | 236,741 | Sep 11, 2014, 04:41 PM |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | Sep 09, 2014 | Option Exercise | $5.23 | 7,825 | 40,925 | 147,983 | Sep 11, 2014, 04:41 PM |
BERGER HARVEY J M D | Chairman & CEO | Sep 09, 2014 | Option Exercise | $5.75 | 124,613 | 716,525 | 1,163,564 | Sep 11, 2014, 04:39 PM |
BERGER HARVEY J M D | Chairman & CEO | Sep 09, 2014 | Option Exercise | $5.23 | 150,000 | 784,500 | 1,294,277 | Sep 11, 2014, 04:39 PM |
BERGER HARVEY J M D | Chairman & CEO | Sep 03, 2014 | Buy | $6.31 | 12,500 | 78,859 | 1,739,286 | Sep 11, 2014, 04:39 PM |
BERGER HARVEY J M D | Chairman & CEO | Sep 02, 2014 | Buy | $6.22 | 12,500 | 77,777 | 1,726,786 | Sep 11, 2014, 04:39 PM |
Schlesinger Sarah J. | Director | Aug 13, 2014 | Buy | $5.71 | 1,300 | 7,423 | 2,600 | Sep 11, 2014, 04:38 PM |
Schlesinger Sarah J. | Director | Aug 12, 2014 | Buy | $5.52 | 1,300 | 7,176 | 1,300 | Sep 11, 2014, 04:38 PM |
Schlesinger Sarah J. | Director | Sep 10, 2014 | Buy | $5.75 | 1,300 | 7,475 | 5,200 | Sep 11, 2014, 04:38 PM |
Schlesinger Sarah J. | Director | Sep 09, 2014 | Buy | $5.93 | 1,300 | 7,709 | 3,900 | Sep 11, 2014, 04:38 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Sep 02, 2014 | Option Exercise | $5.23 | 50,000 | 261,500 | 305,960 | Sep 04, 2014, 04:24 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Sep 02, 2014 | Sale | $6.22 | 50,000 | 310,835 | 280,960 | Sep 04, 2014, 04:24 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Sep 02, 2014 | Sale | $6.21 | 2,696 | 16,753 | 88,678 | Sep 04, 2014, 04:22 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 02, 2014 | Option Exercise | $1.30 | 26,250 | 34,125 | 179,705 | Sep 04, 2014, 04:21 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 02, 2014 | Sale | $6.22 | 56,650 | 352,227 | 153,455 | Sep 04, 2014, 04:21 PM |
DENNER ALEXANDER J | Director | Aug 15, 2014 | Buy | $5.83 | 615,466 | 3,588,167 | 7,798,665 | Aug 19, 2014, 06:04 PM |
DENNER ALEXANDER J | Director | Aug 15, 2014 | Buy | $5.83 | 234,534 | 1,367,333 | 5,051,335 | Aug 19, 2014, 06:04 PM |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | Jul 15, 2014 | Option Exercise | $5.57 | 2,608 | 14,527 | 236,034 | Jul 17, 2014, 05:04 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jul 15, 2014 | Option Exercise | $5.57 | 2,608 | 14,527 | 153,455 | Jul 17, 2014, 05:03 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Jul 15, 2014 | Option Exercise | $5.57 | 2,608 | 14,527 | 91,374 | Jul 17, 2014, 05:02 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 15, 2014 | Option Exercise | $5.57 | 4,564 | 25,421 | 413,565 | Jul 17, 2014, 05:02 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Jul 15, 2014 | Option Exercise | $5.57 | 2,608 | 14,527 | 95,299 | Jul 17, 2014, 05:01 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Jul 15, 2014 | Option Exercise | $5.57 | 4,564 | 25,421 | 280,960 | Jul 17, 2014, 05:00 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 15, 2014 | Option Exercise | $5.57 | 15,556 | 86,647 | 1,122,621 | Jul 17, 2014, 04:59 PM |
Duvall Martin J | EVP, CCO | Jul 15, 2014 | Option Exercise | $5.57 | 913 | 5,085 | 35,450 | Jul 17, 2014, 04:58 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Jun 02, 2014 | Sale | $6.90 | 3,713 | 25,611 | 84,461 | Jun 04, 2014, 04:29 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Apr 02, 2014 | Sale | $8.21 | 3,400 | 27,916 | 104,296 | Apr 03, 2014, 04:32 PM |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | Apr 02, 2014 | Sale | $8.22 | 2,400 | 19,718 | 230,642 | Apr 03, 2014, 04:31 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Apr 02, 2014 | Sale | $8.22 | 2,400 | 19,720 | 148,063 | Apr 03, 2014, 04:30 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Apr 01, 2014 | Option Exercise | $8.52 | 4,238 | 36,108 | 270,928 | Apr 03, 2014, 04:29 PM |
BERGER HARVEY J M D | Chairman & CEO | Apr 01, 2014 | Option Exercise | $8.52 | 13,584 | 115,736 | 1,129,324 | Apr 03, 2014, 04:28 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Apr 02, 2014 | Sale | $8.21 | 4,250 | 34,907 | 88,174 | Apr 03, 2014, 04:28 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 02, 2014 | Sale | $8.21 | 6,500 | 53,337 | 403,028 | Apr 03, 2014, 04:27 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Mar 19, 2014 | Option Exercise | $8.19 | 2,061 | 16,880 | 78,713 | Mar 21, 2014, 05:30 PM |
Cantor Maria E | SVP, Corporate Affairs and HR | Mar 21, 2014 | Sale | $7.89 | 3,667 | 28,930 | 82,379 | Mar 21, 2014, 05:30 PM |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | Mar 19, 2014 | Option Exercise | $8.19 | 1,506 | 12,334 | 224,642 | Mar 21, 2014, 05:28 PM |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | Mar 21, 2014 | Sale | $7.89 | 1,600 | 12,630 | 227,042 | Mar 21, 2014, 05:28 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 19, 2014 | Option Exercise | $8.19 | 2,061 | 16,880 | 95,596 | Mar 21, 2014, 05:28 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 21, 2014 | Sale | $7.89 | 2,400 | 18,941 | 99,196 | Mar 21, 2014, 05:28 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 19, 2014 | Option Exercise | $8.19 | 2,536 | 20,770 | 140,863 | Mar 21, 2014, 05:21 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 21, 2014 | Sale | $7.89 | 2,400 | 18,936 | 144,463 | Mar 21, 2014, 05:21 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 19, 2014 | Option Exercise | $8.19 | 3,442 | 28,190 | 387,711 | Mar 21, 2014, 05:20 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 21, 2014 | Sale | $7.89 | 6,667 | 52,583 | 394,377 | Mar 21, 2014, 05:20 PM |
Duvall Martin J | EVP, CCO | Mar 20, 2014 | Option Exercise | $8.13 | 529 | 4,301 | 30,340 | Mar 21, 2014, 04:11 PM |
Duvall Martin J | EVP, CCO | Mar 19, 2014 | Option Exercise | $8.19 | 2,618 | 21,441 | 29,203 | Mar 21, 2014, 04:11 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 19, 2014 | Option Exercise | $8.19 | 3,435 | 28,133 | 255,940 | Mar 21, 2014, 04:10 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 20, 2014 | Option Exercise | $8.13 | 2,717 | 22,089 | 261,556 | Mar 21, 2014, 04:10 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 20, 2014 | Option Exercise | $8.13 | 11,084 | 90,113 | 1,097,964 | Mar 21, 2014, 04:09 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 19, 2014 | Option Exercise | $8.19 | 11,711 | 95,913 | 1,075,048 | Mar 21, 2014, 04:09 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Dec 19, 2013 | Sale | $5.14 | 9,750 | 50,115 | 380,319 | Dec 20, 2013, 04:39 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Dec 19, 2013 | Sale | $5.15 | 3,600 | 18,528 | 135,399 | Dec 20, 2013, 04:38 PM |
Cantor Maria E | SVP, Corporate Affairs | Dec 19, 2013 | Sale | $5.14 | 6,375 | 32,767 | 74,274 | Dec 20, 2013, 04:35 PM |
BERGER HARVEY J M D | Chairman & CEO | Dec 18, 2013 | Option Exercise | $4.98 | 29,500 | 146,910 | 1,050,759 | Dec 20, 2013, 04:33 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Dec 19, 2013 | Sale | $5.14 | 5,100 | 26,214 | 91,157 | Dec 20, 2013, 04:33 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Dec 19, 2013 | Sale | $5.14 | 4,500 | 23,130 | 221,398 | Dec 20, 2013, 04:31 PM |
Duvall Martin J | SVP, Commercial Operations | Sep 19, 2013 | Option Exercise | $21.49 | 10,918 | 234,628 | 23,821 | Sep 24, 2013, 04:03 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Sep 06, 2013 | Sale | $22.00 | 8,449 | 185,878 | 370,451 | Sep 10, 2013, 04:32 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Aug 15, 2013 | Option Exercise | $18.11 | 19,342 | 350,284 | 228,243 | Aug 16, 2013, 04:23 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Aug 15, 2013 | Option Exercise | $3.90 | 33,000 | 128,700 | 247,585 | Aug 16, 2013, 04:23 PM |
BERGER HARVEY J M D | Chairman & CEO | Aug 13, 2013 | Sale | $18.11 | 50,000 | 905,555 | 1,305,661 | Aug 15, 2013, 04:26 PM |
BERGER HARVEY J M D | Chairman & CEO | Aug 14, 2013 | Sale | $18.37 | 3,157 | 57,999 | 0 | Aug 15, 2013, 04:26 PM |
BERGER HARVEY J M D | Chairman & CEO | Aug 14, 2013 | Sale | $18.51 | 62,902 | 1,164,335 | 1,242,759 | Aug 15, 2013, 04:26 PM |
BERGER HARVEY J M D | Chairman & CEO | Aug 13, 2013 | Sale | $18.36 | 2,700 | 49,570 | 3,157 | Aug 15, 2013, 04:26 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jul 18, 2013 | Sale | $19.79 | 6,400 | 126,639 | 129,978 | Jul 18, 2013, 05:53 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Jul 18, 2013 | Sale | $19.79 | 8,000 | 158,290 | 216,898 | Jul 18, 2013, 05:53 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Jul 18, 2013 | Sale | $19.79 | 6,400 | 126,642 | 83,507 | Jul 18, 2013, 05:51 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Jul 18, 2013 | Sale | $19.79 | 6,400 | 126,655 | 67,282 | Jul 18, 2013, 05:50 PM |
Keane Raymond T | SVP General Counsel & CCO | Jul 18, 2013 | Sale | $19.79 | 8,000 | 158,286 | 62,096 | Jul 18, 2013, 05:49 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 18, 2013 | Sale | $19.79 | 14,000 | 277,045 | 378,900 | Jul 18, 2013, 05:47 PM |
Cantor Maria E | SVP, Corporate Affairs | Jul 18, 2013 | Sale | $19.79 | 8,000 | 158,299 | 67,724 | Jul 18, 2013, 05:46 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 17, 2013 | Sale | $19.60 | 2,700 | 52,912 | 5,857 | Jul 18, 2013, 04:21 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 17, 2013 | Sale | $19.61 | 50,000 | 980,705 | 1,355,861 | Jul 18, 2013, 04:21 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 16, 2013 | Sale | $20.97 | 2,700 | 56,623 | 8,557 | Jul 18, 2013, 04:21 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 16, 2013 | Sale | $19.91 | 144,000 | 2,866,478 | 1,405,861 | Jul 18, 2013, 04:21 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 15, 2013 | Option Exercise | $20.98 | 34,776 | 729,600 | 1,549,861 | Jul 17, 2013, 04:42 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Jul 15, 2013 | Option Exercise | $20.98 | 13,230 | 277,565 | 214,585 | Jul 17, 2013, 04:38 PM |
BERGER HARVEY J M D | Chairman & CEO | Jun 19, 2013 | Sale | $18.00 | 5,800 | 104,415 | 1,511,037 | Jun 21, 2013, 04:19 PM |
BERGER HARVEY J M D | Chairman & CEO | Jun 19, 2013 | Sale | $18.00 | 5,400 | 97,208 | 11,257 | Jun 21, 2013, 04:19 PM |
BERGER HARVEY J M D | Chairman & CEO | May 15, 2013 | Sale | $18.14 | 2,700 | 48,983 | 16,657 | May 16, 2013, 04:38 PM |
BERGER HARVEY J M D | Chairman & CEO | May 15, 2013 | Sale | $18.22 | 37,098 | 675,970 | 1,516,837 | May 16, 2013, 04:38 PM |
BERGER HARVEY J M D | Chairman & CEO | May 14, 2013 | Sale | $18.00 | 2,700 | 48,600 | 19,357 | May 16, 2013, 04:38 PM |
BERGER HARVEY J M D | Chairman & CEO | May 14, 2013 | Sale | $18.01 | 50,000 | 900,295 | 1,553,935 | May 16, 2013, 04:38 PM |
BERGER HARVEY J M D | Chairman & CEO | Apr 17, 2013 | Sale | $18.00 | 5,400 | 97,201 | 22,057 | Apr 22, 2013, 05:07 PM |
BERGER HARVEY J M D | Chairman & CEO | Apr 17, 2013 | Sale | $18.01 | 100,000 | 1,800,590 | 1,667,521 | Apr 22, 2013, 05:07 PM |
Keane Raymond T | SVP General Counsel & CCO | Apr 02, 2013 | Sale | $18.05 | 2,583 | 46,625 | 54,096 | Apr 03, 2013, 04:58 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Apr 02, 2013 | Sale | $18.04 | 3,400 | 61,339 | 73,907 | Apr 03, 2013, 04:57 PM |
Cantor Maria E | SVP, Corporate Affairs | Apr 02, 2013 | Sale | $18.04 | 4,250 | 76,665 | 62,275 | Apr 03, 2013, 04:55 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 02, 2013 | Sale | $18.04 | 6,500 | 117,245 | 363,705 | Apr 03, 2013, 04:53 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Apr 02, 2013 | Sale | $18.04 | 2,400 | 43,295 | 57,682 | Apr 03, 2013, 04:52 PM |
BERGER HARVEY J M D | Chairman & CEO | Apr 01, 2013 | Option Exercise | $18.30 | 19,688 | 360,290 | 1,767,521 | Apr 03, 2013, 04:51 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Apr 02, 2013 | Sale | $18.05 | 2,400 | 43,322 | 208,898 | Apr 03, 2013, 04:47 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 26, 2013 | Sale | $18.75 | 12,933 | 242,492 | 191,555 | Mar 26, 2013, 04:57 PM |
Keane Raymond T | SVP General Counsel & CCO | Mar 25, 2013 | Sale | $18.87 | 13,167 | 248,482 | 51,513 | Mar 26, 2013, 04:40 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Mar 25, 2013 | Sale | $18.87 | 8,133 | 153,482 | 54,082 | Mar 26, 2013, 04:38 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 25, 2013 | Sale | $18.87 | 10,533 | 198,807 | 205,298 | Mar 26, 2013, 04:36 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 25, 2013 | Sale | $18.88 | 5,333 | 100,672 | 68,807 | Mar 26, 2013, 04:36 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 25, 2013 | Sale | $18.87 | 19,167 | 361,766 | 357,205 | Mar 26, 2013, 04:34 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 25, 2013 | Sale | $18.87 | 12,933 | 244,079 | 114,271 | Mar 26, 2013, 04:32 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 22, 2013 | Option Exercise | $19.38 | 5,877 | 113,896 | 58,025 | Mar 26, 2013, 04:32 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 22, 2013 | Option Exercise | $19.38 | 46,148 | 894,348 | 1,745,543 | Mar 26, 2013, 04:30 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 20, 2013 | Option Exercise | $20.45 | 16,065 | 328,529 | 1,694,024 | Mar 22, 2013, 07:07 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 20, 2013 | Option Exercise | $20.45 | 2,722 | 55,665 | 172,155 | Mar 22, 2013, 07:02 PM |
Duvall Martin J | SVP, Commercial Operations | Mar 22, 2013 | Sale | $19.53 | 576 | 11,249 | 2,854 | Mar 22, 2013, 06:51 PM |
Keane Raymond T | SVP General Counsel & CCO | Mar 22, 2013 | Sale | $19.46 | 2,334 | 45,423 | 38,347 | Mar 22, 2013, 06:38 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Mar 22, 2013 | Sale | $19.46 | 2,400 | 46,698 | 41,882 | Mar 22, 2013, 06:31 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 22, 2013 | Sale | $19.46 | 2,400 | 46,694 | 60,807 | Mar 22, 2013, 06:29 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 22, 2013 | Sale | $19.46 | 2,400 | 46,694 | 94,871 | Mar 22, 2013, 06:09 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 22, 2013 | Sale | $19.46 | 1,600 | 31,135 | 189,498 | Mar 22, 2013, 06:05 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 22, 2013 | Sale | $19.46 | 6,667 | 129,718 | 338,039 | Mar 22, 2013, 06:03 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 22, 2013 | Sale | $19.45 | 3,667 | 71,335 | 42,235 | Mar 22, 2013, 05:14 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 13, 2013 | Sale | $22.06 | 50,000 | 1,102,990 | 1,676,089 | Mar 14, 2013, 04:33 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 13, 2013 | Sale | $22.07 | 2,700 | 59,587 | 27,457 | Mar 14, 2013, 04:33 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 12, 2013 | Sale | $22.04 | 50,000 | 1,101,755 | 1,726,089 | Mar 14, 2013, 04:33 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 12, 2013 | Sale | $22.04 | 2,700 | 59,516 | 30,157 | Mar 14, 2013, 04:33 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 12, 2013 | Sale | $22.00 | 2,105 | 46,310 | 38,568 | Mar 13, 2013, 04:35 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 04, 2013 | Sale | $21.00 | 9,838 | 206,598 | 331,372 | Mar 05, 2013, 04:44 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jan 15, 2013 | Option Exercise | $5.05 | 57,939 | 292,414 | 341,210 | Jan 17, 2013, 04:44 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Jan 02, 2013 | Sale | $20.08 | 25,000 | 501,890 | 166,543 | Jan 03, 2013, 04:30 PM |
LAVIDAS ATHANESE | Director | Dec 21, 2012 | Sale | $20.31 | 10,500 | 213,209 | 80,131 | Dec 27, 2012, 04:45 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Dec 20, 2012 | Option Exercise | $5.23 | 27,000 | 141,210 | 282,940 | Dec 21, 2012, 04:28 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Dec 18, 2012 | Option Exercise | $20.18 | 3,758 | 75,836 | 91,271 | Dec 20, 2012, 04:46 PM |
Cantor Maria E | SVP, Corporate Affairs | Dec 18, 2012 | Option Exercise | $20.18 | 5,324 | 107,438 | 40,673 | Dec 20, 2012, 04:44 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Dec 18, 2012 | Option Exercise | $20.18 | 8,142 | 164,306 | 255,940 | Dec 20, 2012, 04:41 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Dec 18, 2012 | Option Exercise | $20.18 | 8,142 | 164,306 | 191,357 | Dec 20, 2012, 04:39 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Dec 18, 2012 | Option Exercise | $20.18 | 5,324 | 107,438 | 57,207 | Dec 20, 2012, 04:37 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Dec 18, 2012 | Option Exercise | $20.18 | 3,758 | 75,836 | 38,282 | Dec 20, 2012, 04:35 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Dec 18, 2012 | Option Exercise | $20.18 | 3,758 | 75,836 | 187,098 | Dec 20, 2012, 04:30 PM |
BERGER HARVEY J M D | Chairman & CEO | Dec 18, 2012 | Option Exercise | $20.18 | 26,094 | 526,577 | 2,226,089 | Dec 20, 2012, 04:27 PM |
Keane Raymond T | SVP General Counsel & CCO | Dec 18, 2012 | Option Exercise | $20.18 | 3,236 | 65,302 | 36,014 | Dec 20, 2012, 04:24 PM |
LAMARCHE JAY R | Director | Oct 01, 2012 | Sale | $24.99 | 10,000 | 249,932 | 400,705 | Oct 03, 2012, 04:02 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Oct 01, 2012 | Option Exercise | $1.30 | 7,500 | 9,750 | 93,019 | Oct 02, 2012, 04:13 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Oct 01, 2012 | Sale | $25.00 | 7,500 | 187,500 | 85,519 | Oct 02, 2012, 04:13 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Oct 01, 2012 | Sale | $24.17 | 25,000 | 604,187 | 179,767 | Oct 02, 2012, 04:11 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 19, 2012 | Option Exercise | $1.30 | 7,500 | 9,750 | 93,019 | Sep 20, 2012, 12:34 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 19, 2012 | Sale | $24.00 | 7,500 | 180,000 | 85,519 | Sep 20, 2012, 12:34 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 19, 2012 | Option Exercise | $5.23 | 11,375 | 59,491 | 201,231 | Sep 20, 2012, 12:32 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 19, 2012 | Sale | $24.00 | 19,375 | 465,000 | 189,856 | Sep 20, 2012, 12:32 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 11, 2012 | Option Exercise | $1.30 | 7,500 | 9,750 | 93,019 | Sep 12, 2012, 04:10 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Sep 11, 2012 | Sale | $23.00 | 7,500 | 172,500 | 85,519 | Sep 12, 2012, 04:10 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 11, 2012 | Option Exercise | $5.23 | 11,375 | 59,491 | 201,231 | Sep 12, 2012, 04:05 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 11, 2012 | Sale | $23.00 | 19,375 | 445,625 | 189,856 | Sep 12, 2012, 04:05 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 11, 2012 | Option Exercise | $5.23 | 11,375 | 59,491 | 201,231 | Sep 12, 2012, 04:02 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 11, 2012 | Sale | $23.00 | 19,375 | 445,625 | 189,856 | Sep 12, 2012, 04:02 PM |
LAMARCHE JAY R | Director | Sep 06, 2012 | Option Exercise | $2.66 | 15,000 | 39,900 | 533,893 | Sep 11, 2012, 04:15 PM |
LAMARCHE JAY R | Director | Sep 06, 2012 | Option Exercise | $2.66 | 15,000 | 39,900 | 525,205 | Sep 07, 2012, 04:55 PM |
Keane Raymond T | SVP General Counsel & CCO | Sep 06, 2012 | Option Exercise | $2.39 | 10,000 | 23,900 | 41,500 | Sep 07, 2012, 04:18 PM |
Keane Raymond T | SVP General Counsel & CCO | Sep 06, 2012 | Sale | $22.00 | 10,000 | 220,000 | 31,500 | Sep 07, 2012, 04:18 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 06, 2012 | Option Exercise | $5.23 | 11,375 | 59,491 | 205,700 | Sep 07, 2012, 04:16 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 06, 2012 | Sale | $22.00 | 19,375 | 426,250 | 197,856 | Sep 07, 2012, 04:16 PM |
Keane Raymond T | SVP General Counsel & CCO | Sep 04, 2012 | Sale | $21.00 | 7,780 | 163,380 | 31,500 | Sep 05, 2012, 04:18 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 04, 2012 | Option Exercise | $5.23 | 8,050 | 42,102 | 221,906 | Sep 05, 2012, 04:15 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Sep 04, 2012 | Sale | $21.00 | 16,050 | 337,050 | 213,856 | Sep 05, 2012, 04:15 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Aug 30, 2012 | Option Exercise | $3.25 | 10,001 | 32,503 | 244,170 | Sep 04, 2012, 04:08 PM |
LAMARCHE JAY R | Director | Aug 15, 2012 | Sale | $20.00 | 20,000 | 400,032 | 518,893 | Aug 16, 2012, 04:10 PM |
Keane Raymond T | SVP General Counsel & CCO | Aug 15, 2012 | Option Exercise | $2.39 | 10,000 | 23,900 | 49,280 | Aug 16, 2012, 04:09 PM |
Keane Raymond T | SVP General Counsel & CCO | Aug 15, 2012 | Sale | $20.00 | 10,000 | 200,000 | 39,280 | Aug 16, 2012, 04:09 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Aug 15, 2012 | Option Exercise | $7.56 | 36,843 | 278,533 | 271,012 | Aug 16, 2012, 04:07 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Aug 15, 2012 | Sale | $20.00 | 36,843 | 736,860 | 234,169 | Aug 16, 2012, 04:07 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Aug 15, 2012 | Sale | $20.00 | 8,000 | 160,000 | 213,856 | Aug 16, 2012, 04:05 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Jul 30, 2012 | Option Exercise | $5.49 | 25,000 | 137,250 | 61,640 | Aug 01, 2012, 04:45 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Jul 30, 2012 | Sale | $19.00 | 28,600 | 543,400 | 33,040 | Aug 01, 2012, 04:45 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Jul 30, 2012 | Sale | $19.00 | 8,000 | 152,000 | 221,856 | Aug 01, 2012, 04:12 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 30, 2012 | Option Exercise | $5.23 | 23,234 | 121,514 | 257,403 | Aug 01, 2012, 04:07 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jul 30, 2012 | Sale | $19.00 | 23,234 | 441,446 | 234,169 | Aug 01, 2012, 04:07 PM |
Keane Raymond T | SVP General Counsel & CCO | Jul 30, 2012 | Sale | $19.00 | 10,000 | 190,000 | 39,280 | Aug 01, 2012, 04:06 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jul 30, 2012 | Option Exercise | $1.30 | 7,500 | 9,750 | 93,091 | Aug 01, 2012, 04:05 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jul 30, 2012 | Sale | $19.00 | 7,500 | 142,500 | 85,519 | Aug 01, 2012, 04:05 PM |
Cantor Maria E | SVP, Corporate Affairs | Jul 30, 2012 | Option Exercise | $7.82 | 6,478 | 50,658 | 39,326 | Aug 01, 2012, 04:04 PM |
Cantor Maria E | SVP, Corporate Affairs | Jul 30, 2012 | Sale | $19.00 | 6,478 | 123,082 | 32,848 | Aug 01, 2012, 04:04 PM |
Keane Raymond T | SVP General Counsel & CCO | Jul 26, 2012 | Option Exercise | $2.39 | 10,000 | 23,900 | 59,280 | Jul 27, 2012, 03:03 PM |
Keane Raymond T | SVP General Counsel & CCO | Jul 26, 2012 | Sale | $18.00 | 10,000 | 180,000 | 49,280 | Jul 27, 2012, 03:03 PM |
LAVIDAS ATHANESE | Director | Jul 20, 2012 | Sale | $18.00 | 5,000 | 89,977 | 90,631 | Jul 23, 2012, 04:33 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Jul 02, 2012 | Sale | $17.64 | 25,000 | 440,950 | 204,767 | Jul 05, 2012, 04:23 PM |
Cantor Maria E | SVP, Corporate Affairs | Jun 25, 2012 | Sale | $17.11 | 1,765 | 30,199 | 32,337 | Jun 26, 2012, 04:29 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jun 22, 2012 | Option Exercise | $1.30 | 7,500 | 9,750 | 92,595 | Jun 25, 2012, 04:30 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Jun 22, 2012 | Sale | $17.50 | 7,500 | 131,269 | 85,095 | Jun 25, 2012, 04:30 PM |
LAVIDAS ATHANESE | Director | Jun 20, 2012 | Sale | $17.41 | 5,000 | 87,028 | 95,631 | Jun 22, 2012, 04:30 PM |
Cantor Maria E | SVP, Corporate Affairs | Jun 19, 2012 | Option Exercise | $3.08 | 7,500 | 23,100 | 41,602 | Jun 21, 2012, 04:03 PM |
Cantor Maria E | SVP, Corporate Affairs | Jun 19, 2012 | Sale | $18.00 | 7,500 | 135,000 | 34,102 | Jun 21, 2012, 04:03 PM |
BERGER HARVEY J M D | Chairman & CEO | Jun 13, 2012 | Option Exercise | $16.79 | 5,955 | 99,984 | 2,189,683 | Jun 15, 2012, 04:27 PM |
BERGER HARVEY J M D | Chairman & CEO | Jun 13, 2012 | Option Exercise | $4.05 | 24,691 | 99,999 | 2,195,638 | Jun 15, 2012, 04:27 PM |
LAVIDAS ATHANESE | Director | Jun 05, 2012 | Option Exercise | $6.39 | 25,000 | 159,750 | 125,631 | Jun 07, 2012, 04:21 PM |
LAVIDAS ATHANESE | Director | Jun 05, 2012 | Sale | $16.05 | 25,000 | 401,280 | 100,631 | Jun 07, 2012, 04:21 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | May 21, 2012 | Option Exercise | $4.19 | 26,075 | 109,254 | 263,931 | May 23, 2012, 04:05 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 26, 2012 | Sale | $16.00 | 8,000 | 128,000 | 229,856 | May 23, 2012, 04:05 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | May 21, 2012 | Sale | $16.54 | 26,075 | 431,398 | 237,856 | May 23, 2012, 04:05 PM |
LAVIDAS ATHANESE | Director | May 21, 2012 | Sale | $16.54 | 5,000 | 82,690 | 100,631 | May 23, 2012, 04:04 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | May 16, 2012 | Sale | $17.50 | 22,130 | 387,275 | 36,640 | May 17, 2012, 04:30 PM |
FITZGERALD EDWARD M | Executive VP, CFO | May 03, 2012 | Option Exercise | $4.63 | 60,000 | 277,800 | 229,548 | May 04, 2012, 04:33 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | May 02, 2012 | Option Exercise | $7.44 | 20,000 | 148,800 | 253,778 | May 04, 2012, 04:31 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | May 02, 2012 | Sale | $17.00 | 20,000 | 340,000 | 233,778 | May 04, 2012, 04:31 PM |
Haluska Frank | SVP, Clinical R&D, CMO | May 02, 2012 | Option Exercise | $2.39 | 3,000 | 7,170 | 52,781 | May 04, 2012, 04:29 PM |
Haluska Frank | SVP, Clinical R&D, CMO | May 02, 2012 | Sale | $17.00 | 3,000 | 51,000 | 49,781 | May 04, 2012, 04:29 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | May 02, 2012 | Option Exercise | $4.19 | 11,375 | 47,661 | 257,231 | May 04, 2012, 04:27 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | May 02, 2012 | Sale | $17.00 | 19,375 | 329,375 | 245,856 | May 04, 2012, 04:27 PM |
LAVIDAS ATHANESE | Director | Apr 20, 2012 | Sale | $15.06 | 10,000 | 150,558 | 105,631 | Apr 24, 2012, 04:30 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Apr 17, 2012 | Option Exercise | $4.63 | 40,000 | 185,200 | 209,548 | Apr 18, 2012, 04:33 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Apr 17, 2012 | Sale | $15.00 | 40,000 | 600,000 | 169,548 | Apr 18, 2012, 04:33 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 17, 2012 | Sale | $15.00 | 7,111 | 106,665 | 233,778 | Apr 17, 2012, 04:28 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 13, 2012 | Sale | $14.83 | 31,600 | 468,628 | 240,889 | Apr 17, 2012, 04:28 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Apr 12, 2012 | Sale | $15.39 | 17,062 | 262,576 | 58,770 | Apr 16, 2012, 04:27 PM |
LAVIDAS ATHANESE | Director | Apr 09, 2012 | Sale | $15.76 | 15,000 | 236,350 | 115,631 | Apr 11, 2012, 04:31 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Apr 02, 2012 | Option Exercise | $7.82 | 10,667 | 83,416 | 86,499 | Apr 04, 2012, 04:02 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Apr 02, 2012 | Sale | $16.11 | 10,667 | 171,887 | 75,832 | Apr 04, 2012, 04:02 PM |
Cantor Maria E | SVP, Corporate Affairs | Apr 03, 2012 | Sale | $16.18 | 3,400 | 55,027 | 33,327 | Apr 03, 2012, 06:02 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 03, 2012 | Sale | $16.18 | 5,200 | 84,134 | 272,489 | Apr 03, 2012, 05:58 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 26, 2012 | Sale | $16.34 | 26,061 | 425,876 | 264,689 | Apr 03, 2012, 05:58 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Apr 03, 2012 | Sale | $16.19 | 2,400 | 38,844 | 245,856 | Apr 03, 2012, 05:57 PM |
Keane Raymond T | SVP General Counsel & CCO | Apr 03, 2012 | Sale | $16.19 | 2,067 | 33,455 | 48,980 | Apr 03, 2012, 05:56 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Apr 03, 2012 | Sale | $16.18 | 5,200 | 84,156 | 167,880 | Apr 03, 2012, 05:56 PM |
BERGER HARVEY J M D | Chairman & CEO | Apr 02, 2012 | Option Exercise | $16.23 | 17,396 | 282,337 | 2,170,947 | Apr 03, 2012, 05:54 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Apr 02, 2012 | Option Exercise | $16.23 | 1,905 | 30,918 | 85,095 | Apr 03, 2012, 05:54 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Apr 03, 2012 | Sale | $16.18 | 4,250 | 68,767 | 49,781 | Apr 03, 2012, 05:53 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Apr 03, 2012 | Sale | $16.18 | 2,400 | 38,836 | 75,832 | Apr 03, 2012, 05:52 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 26, 2012 | Option Exercise | $6.39 | 7,500 | 47,925 | 298,250 | Mar 28, 2012, 04:18 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 26, 2012 | Sale | $16.00 | 7,500 | 120,000 | 290,750 | Mar 28, 2012, 04:18 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 26, 2012 | Option Exercise | $4.19 | 11,375 | 47,661 | 253,631 | Mar 28, 2012, 04:17 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 26, 2012 | Sale | $16.00 | 11,375 | 182,000 | 242,256 | Mar 28, 2012, 04:17 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Mar 26, 2012 | Option Exercise | $5.49 | 25,000 | 137,250 | 97,232 | Mar 28, 2012, 04:16 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Mar 26, 2012 | Sale | $16.50 | 25,000 | 412,500 | 72,232 | Mar 28, 2012, 04:16 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 26, 2012 | Option Exercise | $3.08 | 6,000 | 18,480 | 52,227 | Mar 28, 2012, 04:15 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 27, 2012 | Sale | $16.23 | 18,000 | 292,138 | 28,227 | Mar 28, 2012, 04:15 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 26, 2012 | Sale | $16.00 | 6,000 | 96,000 | 46,227 | Mar 28, 2012, 04:15 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 26, 2012 | Option Exercise | $2.39 | 3,000 | 7,170 | 48,531 | Mar 28, 2012, 04:15 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 26, 2012 | Sale | $16.00 | 3,000 | 48,000 | 45,531 | Mar 28, 2012, 04:15 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 23, 2012 | Sale | $15.41 | 6,667 | 102,718 | 45,531 | Mar 26, 2012, 04:45 PM |
Keane Raymond T | SVP General Counsel & CCO | Mar 23, 2012 | Sale | $15.41 | 10,533 | 162,271 | 45,880 | Mar 26, 2012, 04:44 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Mar 23, 2012 | Sale | $15.29 | 24,901 | 380,712 | 89,000 | Mar 26, 2012, 04:43 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 23, 2012 | Sale | $15.41 | 12,933 | 199,239 | 160,080 | Mar 26, 2012, 04:41 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 22, 2012 | Option Exercise | $15.68 | 10,343 | 162,178 | 81,000 | Mar 26, 2012, 04:39 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 22, 2012 | Option Exercise | $15.68 | 40,776 | 639,368 | 2,146,676 | Mar 26, 2012, 04:38 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 23, 2012 | Sale | $15.41 | 15,333 | 236,211 | 290,750 | Mar 26, 2012, 04:37 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 23, 2012 | Sale | $15.41 | 10,533 | 162,274 | 242,256 | Mar 26, 2012, 04:36 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 20, 2012 | Option Exercise | $15.05 | 10,438 | 157,092 | 2,089,786 | Mar 22, 2012, 04:34 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 20, 2012 | Sale | $15.02 | 18,800 | 282,314 | 226,456 | Mar 21, 2012, 06:08 PM |
Keane Raymond T | SVP General Counsel & CCO | Mar 20, 2012 | Sale | $15.02 | 8,400 | 126,155 | 30,380 | Mar 21, 2012, 06:06 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Mar 20, 2012 | Sale | $15.02 | 15,000 | 225,240 | 38,865 | Mar 21, 2012, 06:05 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Mar 20, 2012 | Sale | $15.02 | 31,200 | 468,605 | 140,680 | Mar 21, 2012, 06:04 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Mar 20, 2012 | Sale | $15.01 | 12,980 | 194,799 | 76,800 | Mar 21, 2012, 06:03 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 20, 2012 | Sale | $15.02 | 36,400 | 546,622 | 267,750 | Mar 21, 2012, 06:02 PM |
Cantor Maria E | SVP, Corporate Affairs | Mar 20, 2012 | Sale | $15.02 | 14,000 | 210,218 | 28,277 | Mar 21, 2012, 06:02 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 16, 2012 | Option Exercise | $4.13 | 15,064 | 62,192 | 213,150 | Mar 19, 2012, 04:30 PM |
BERGER HARVEY J M D | Chairman & CEO | Mar 10, 2012 | Option Exercise | $14.95 | 66,800 | 998,660 | 2,008,424 | Mar 13, 2012, 05:05 PM |
LAMARCHE JAY R | Director | Feb 28, 2012 | Option Exercise | $4.44 | 20,000 | 88,800 | 538,893 | Mar 01, 2012, 04:29 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Feb 28, 2012 | Option Exercise | $3.93 | 11,375 | 44,703 | 209,631 | Mar 01, 2012, 04:28 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Feb 28, 2012 | Sale | $15.50 | 11,375 | 176,313 | 198,256 | Mar 01, 2012, 04:28 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Feb 23, 2012 | Option Exercise | $5.49 | 25,000 | 137,250 | 55,780 | Feb 24, 2012, 04:31 PM |
DODION PIERRE F | SVP, Corp. Dev. & Operations | Feb 23, 2012 | Sale | $15.00 | 25,000 | 375,000 | 30,780 | Feb 24, 2012, 04:31 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Feb 23, 2012 | Sale | $15.00 | 4,100 | 61,500 | 198,256 | Feb 24, 2012, 04:30 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Feb 21, 2012 | Option Exercise | $2.39 | 4,500 | 10,755 | 28,365 | Feb 23, 2012, 04:32 PM |
Haluska Frank | SVP, Clinical R&D, CMO | Feb 21, 2012 | Sale | $14.51 | 4,500 | 65,277 | 23,865 | Feb 23, 2012, 04:32 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Feb 21, 2012 | Option Exercise | $3.90 | 22,800 | 88,920 | 237,456 | Feb 23, 2012, 04:31 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Feb 21, 2012 | Sale | $14.50 | 35,100 | 509,032 | 214,656 | Feb 23, 2012, 04:31 PM |
BERGER HARVEY J M D | Chairman & CEO | Feb 15, 2012 | Option Exercise | $15.05 | 22,912 | 344,826 | 1,915,224 | Feb 17, 2012, 04:30 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 14, 2012 | Option Exercise | $3.90 | 16,500 | 64,350 | 138,150 | Feb 17, 2012, 04:29 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 14, 2012 | Sale | $15.50 | 16,500 | 255,750 | 121,650 | Feb 17, 2012, 04:29 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 14, 2012 | Option Exercise | $4.09 | 76,436 | 312,908 | 196,318 | Feb 16, 2012, 04:29 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Feb 14, 2012 | Sale | $15.12 | 76,436 | 1,155,781 | 119,882 | Feb 16, 2012, 04:29 PM |
Keane Raymond T | SVP General Counsel & CCO | Feb 14, 2012 | Option Exercise | $1.30 | 12,500 | 16,250 | 30,280 | Feb 16, 2012, 04:28 PM |
Keane Raymond T | SVP General Counsel & CCO | Feb 14, 2012 | Sale | $15.13 | 12,500 | 189,178 | 17,780 | Feb 16, 2012, 04:28 PM |
LAMARCHE JAY R | Director | Jan 27, 2012 | Sale | $15.05 | 26,900 | 404,974 | 500,534 | Jan 31, 2012, 04:32 PM |
LAMARCHE JAY R | Director | Jan 26, 2012 | Sale | $15.04 | 3,100 | 46,627 | 527,434 | Jan 27, 2012, 04:24 PM |
BERGER HARVEY J M D | Chairman & CEO | Jul 26, 2011 | Option Exercise | $4.80 | 20,837 | 100,018 | 1,938,136 | Jul 26, 2011, 04:30 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jun 07, 2011 | Option Exercise | $8.65 | 43,766 | 378,576 | 196,318 | Jun 09, 2011, 04:22 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Jun 07, 2011 | Option Exercise | $5.65 | 60,000 | 339,000 | 240,084 | Jun 09, 2011, 04:22 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Jun 07, 2011 | Option Exercise | $8.65 | 44,145 | 381,854 | 214,656 | Jun 09, 2011, 04:21 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Jun 07, 2011 | Option Exercise | $5.65 | 60,000 | 339,000 | 258,801 | Jun 09, 2011, 04:21 PM |
LAMARCHE JAY R | Director | May 09, 2011 | Option Exercise | $9.19 | 15,369 | 141,241 | 530,534 | May 11, 2011, 04:32 PM |
LAMARCHE JAY R | Director | May 09, 2011 | Option Exercise | $5.65 | 25,000 | 141,250 | 545,903 | May 11, 2011, 04:32 PM |
DODION PIERRE F | Senior VP, Corp. Development | Apr 11, 2011 | Option Exercise | $7.76 | 7,938 | 61,599 | 30,780 | Apr 13, 2011, 06:33 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Apr 11, 2011 | Option Exercise | $7.76 | 15,875 | 123,190 | 59,010 | Apr 13, 2011, 06:31 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Apr 11, 2011 | Option Exercise | $7.76 | 13,289 | 103,123 | 180,084 | Apr 13, 2011, 06:30 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Apr 11, 2011 | Option Exercise | $7.76 | 6,985 | 54,204 | 198,801 | Apr 13, 2011, 06:29 PM |
FITZGERALD EDWARD M | Executive VP, CFO | Apr 11, 2011 | Option Exercise | $7.76 | 10,067 | 78,120 | 93,880 | Apr 13, 2011, 06:27 PM |
LAMARCHE JAY R | Director | Mar 25, 2011 | Sale | $7.01 | 25,000 | 175,277 | 520,903 | Mar 29, 2011, 04:29 PM |
Keane Raymond T | SVP General Counsel & CCO | Mar 22, 2011 | Option Exercise | $6.39 | 8,554 | 54,660 | 17,780 | Mar 24, 2011, 05:41 PM |
Haluska Frank | VP, Clinical R&D, CMO | Mar 22, 2011 | Option Exercise | $6.39 | 4,400 | 28,116 | 23,865 | Mar 24, 2011, 05:38 PM |
DODION PIERRE F | Senior VP, Corp. Development | Mar 22, 2011 | Option Exercise | $6.39 | 6,616 | 42,276 | 13,718 | Mar 24, 2011, 05:35 PM |
CLACKSON TIMOTHY P | President, R&D, CSO | Mar 22, 2011 | Option Exercise | $6.39 | 12,273 | 78,424 | 141,373 | Mar 24, 2011, 05:31 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Mar 22, 2011 | Option Exercise | $6.39 | 10,449 | 66,769 | 24,885 | Mar 24, 2011, 05:30 PM |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | Mar 22, 2011 | Option Exercise | $6.39 | 8,509 | 54,373 | 181,910 | Mar 24, 2011, 05:29 PM |
LAMARCHE JAY R | Director | Feb 02, 2011 | Sale | $6.48 | 25,000 | 161,925 | 545,903 | Feb 04, 2011, 04:16 PM |
LAMARCHE JAY R | Director | Jan 11, 2011 | Sale | $5.51 | 25,000 | 137,675 | 560,003 | Jan 14, 2011, 04:23 PM |
LAMARCHE JAY R | Director | Jan 11, 2011 | Sale | $5.50 | 25,000 | 137,388 | 560,003 | Jan 13, 2011, 04:30 PM |
LAMARCHE JAY R | Director | Dec 20, 2010 | Sale | $5.00 | 25,000 | 125,006 | 576,903 | Dec 22, 2010, 04:30 PM |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Oct 26, 2010 | Buy | $3.70 | 3,000 | 11,100 | 3,000 | Oct 27, 2010, 04:30 PM |
CLACKSON TIMOTHY P | Pres., R & D., Chief Sci. Off. | Oct 26, 2010 | Buy | $3.70 | 10,000 | 37,000 | 117,437 | Oct 27, 2010, 04:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Cole Hugh M | SVP, Chief Business Officer | 06/25/2015 | 54,304 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 01/31/2017 | 349,293 |
CLACKSON TIMOTHY P | President, R&D, CSO | 01/31/2017 | 228,886 |
Panayiotopoulos Paris | President and CEO | 01/17/2017 | 788,934 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 01/09/2017 | 250,240 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 01/09/2017 | 760,960 |
CLACKSON TIMOTHY P | President, R&D, CSO | 10/24/2016 | 187,739 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 10/03/2016 | 637,812 |
CLACKSON TIMOTHY P | President, R&D, CSO | 09/28/2016 | 122,311 |
CLACKSON TIMOTHY P | President, R&D, CSO | 09/22/2016 | 268,536 |
CLACKSON TIMOTHY P | President, R&D, CSO | 09/15/2016 | 464,266 |
CLACKSON TIMOTHY P | President, R&D, CSO | 09/15/2016 | 696,398 |
CLACKSON TIMOTHY P | President, R&D, CSO | 08/22/2016 | 203,538 |
CLACKSON TIMOTHY P | President, R&D, CSO | 08/12/2016 | 192,250 |
CLACKSON TIMOTHY P | President, R&D, CSO | 08/12/2016 | 262,500 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/22/2016 | 148,230 |
Panayiotopoulos Paris | President and CEO | 07/13/2016 | 204,283 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/01/2016 | 238,585 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/01/2016 | 459,634 |
Cole Hugh M | SVP, Chief Business Officer | 06/28/2016 | 42,385 |
CLACKSON TIMOTHY P | President, R&D, CSO | 06/22/2016 | 174,638 |
LAVIDAS ATHANESE | Director | 06/15/2016 | 302,787 |
LAVIDAS ATHANESE | Director | 06/14/2016 | 128,800 |
LAVIDAS ATHANESE | Director | 06/13/2016 | 54,900 |
LAVIDAS ATHANESE | Director | 06/15/2016 | 381,137 |
LAVIDAS ATHANESE | Director | 06/14/2016 | 162,852 |
LAVIDAS ATHANESE | Director | 06/13/2016 | 82,050 |
Radaelli Massimo | Director | 06/14/2016 | 30,687 |
Radaelli Massimo | Director | 06/13/2016 | 523,551 |
Radaelli Massimo | Director | 06/10/2016 | 30,494 |
Radaelli Massimo | Director | 06/13/2016 | 657,821 |
Radaelli Massimo | Director | 06/10/2016 | 187,480 |
Radaelli Massimo | Director | 06/14/2016 | 50,834 |
CLACKSON TIMOTHY P | President, R&D, CSO | 05/23/2016 | 143,430 |
Panayiotopoulos Paris | President and CEO | 05/12/2016 | 199,996 |
Haluska Frank | SVP, Clinical R&D, CMO | 04/29/2016 | 40,452 |
Cantor Maria E | SVP, Corporate Affairs | 04/29/2016 | 31,118 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 04/29/2016 | 40,452 |
Cole Hugh M | SVP, Chief Business Officer | 04/29/2016 | 40,452 |
CLACKSON TIMOTHY P | President, R&D, CSO | 05/02/2016 | 83,478 |
Duvall Martin J | EVP, CCO | 04/29/2016 | 42,003 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/22/2016 | 157,864 |
DesRosier Thomas | EVP, General Counsel | 02/18/2016 | 92,401 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/22/2016 | 156,871 |
Duvall Martin J | EVP, CCO | 03/19/2016 | 25,867 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 03/21/2016 | 15,356 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/21/2016 | 25,871 |
Cantor Maria E | SVP, Corporate Affairs | 03/19/2016 | 23,102 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/19/2016 | 35,039 |
FITZGERALD EDWARD M | Executive VP | 03/21/2016 | 35,037 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/21/2016 | 23,116 |
Cole Hugh M | SVP, Chief Business Officer | 03/16/2016 | 15,140 |
Cole Hugh M | SVP, Chief Business Officer | 03/16/2016 | 46,575 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/15/2016 | 141,009 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/15/2016 | 4,875 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/03/2016 | 58,866 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 03/03/2016 | 58,887 |
Duvall Martin J | EVP, CCO | 03/03/2016 | 58,863 |
Cantor Maria E | SVP, Corporate Affairs | 03/03/2016 | 58,869 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/02/2016 | 150,282 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/03/2016 | 58,867 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/03/2016 | 58,852 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/03/2016 | 64,733 |
Panayiotopoulos Paris | President and CEO | 02/01/2016 | 299,996 |
Duvall Martin J | EVP, CCO | 02/01/2016 | 70,578 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/01/2016 | 70,517 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 02/01/2016 | 70,548 |
Haluska Frank | SVP, Clinical R&D, CMO | 02/01/2016 | 77,587 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 02/01/2016 | 70,515 |
FITZGERALD EDWARD M | Executive VP, CFO | 02/01/2016 | 70,515 |
Cantor Maria E | SVP, Corporate Affairs | 02/01/2016 | 77,745 |
BERGER HARVEY J M D | Chairman & CEO | 12/31/2015 | 1,777,381 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 09/28/2015 | 32,315 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/28/2015 | 32,315 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/28/2015 | 32,315 |
Duvall Martin J | EVP, CCO | 09/28/2015 | 32,317 |
Cantor Maria E | SVP, Corporate Affairs | 09/28/2015 | 32,327 |
FITZGERALD EDWARD M | Executive VP, CFO | 09/28/2015 | 56,551 |
Haluska Frank | SVP, Clinical R&D, CMO | 09/28/2015 | 35,502 |
CLACKSON TIMOTHY P | President, R&D, CSO | 09/28/2015 | 56,560 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 09/28/2015 | 32,315 |
Cantor Maria E | SVP, Corporate Affairs | 09/01/2015 | 24,557 |
FITZGERALD EDWARD M | Executive VP, CFO | 08/28/2015 | 328,580 |
Cantor Maria E | SVP, Corporate Affairs | 08/28/2015 | 12,680 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/16/2015 | 59,797 |
Duvall Martin J | EVP, CCO | 07/16/2015 | 11,956 |
FITZGERALD EDWARD M | Executive VP, CFO | 07/16/2015 | 59,793 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 07/16/2015 | 34,164 |
Cantor Maria E | SVP, Corporate Affairs | 07/16/2015 | 34,162 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 07/16/2015 | 34,162 |
Haluska Frank | SVP, Clinical R&D, CMO | 07/16/2015 | 37,575 |
BERGER HARVEY J M D | Chairman & CEO | 07/15/2015 | 145,040 |
FITZGERALD EDWARD M | Executive VP, CFO | 05/01/2015 | 453,600 |
FITZGERALD EDWARD M | Executive VP, CFO | 05/01/2015 | 528,000 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/23/2015 | 1,175,777 |
BERGER HARVEY J M D | Chairman & CEO | 03/26/2015 | 1,039,175 |
BERGER HARVEY J M D | Chairman & CEO | 03/26/2015 | 1,134,000 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 03/23/2015 | 17,118 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 03/20/2015 | 21,026 |
Cantor Maria E | SVP, Corporate Affairs and HR | 03/19/2015 | 24,255 |
Cantor Maria E | SVP, Corporate Affairs and HR | 03/23/2015 | 34,491 |
Cantor Maria E | SVP, Corporate Affairs and HR | 03/20/2015 | 31,627 |
Cantor Maria E | SVP, Corporate Affairs and HR | 03/19/2015 | 84,114 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/23/2015 | 25,661 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/20/2015 | 35,390 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/23/2015 | 35,630 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/20/2015 | 47,908 |
Duvall Martin J | EVP, CCO | 03/23/2015 | 7,145 |
Duvall Martin J | EVP, CCO | 03/20/2015 | 35,381 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/23/2015 | 28,229 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/20/2015 | 31,634 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/19/2015 | 156,167 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/19/2015 | 185,913 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/23/2015 | 57,016 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/20/2015 | 47,910 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 03/23/2015 | 17,118 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 03/20/2015 | 21,026 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/16/2015 | 9,750 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/16/2015 | 296,651 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/20/2015 | 173,419 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/20/2015 | 392,280 |
BERGER HARVEY J M D | Chairman & CEO | 02/12/2015 | 86,280 |
BERGER HARVEY J M D | Chairman & CEO | 02/11/2015 | 84,569 |
Haluska Frank | SVP, Clinical R&D, CMO | 02/02/2015 | 102,107 |
Cantor Maria E | SVP, Corporate Affairs and HR | 02/02/2015 | 102,089 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 02/02/2015 | 92,823 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/02/2015 | 92,820 |
Duvall Martin J | EVP, CCO | 02/02/2015 | 92,823 |
FITZGERALD EDWARD M | Executive VP, CFO | 02/02/2015 | 92,849 |
BERSTEIN DAVID L | SVP, Chief IP Counsel | 02/02/2015 | 92,826 |
BERGER HARVEY J M D | Chairman & CEO | 01/23/2015 | 77,250 |
BERGER HARVEY J M D | Chairman & CEO | 01/22/2015 | 76,990 |
Schlesinger Sarah J. | Director | 01/13/2015 | 9,061 |
Schlesinger Sarah J. | Director | 01/14/2015 | 8,125 |
BERGER HARVEY J M D | Chairman & CEO | 12/18/2014 | 81,770 |
BERGER HARVEY J M D | Chairman & CEO | 12/17/2014 | 76,875 |
Schlesinger Sarah J. | Director | 12/17/2014 | 7,943 |
Schlesinger Sarah J. | Director | 12/16/2014 | 7,891 |
Cantor Maria E | SVP, Corporate Affairs and HR | 11/24/2014 | 12,243 |
BERGER HARVEY J M D | Chairman & CEO | 11/20/2014 | 76,889 |
BERGER HARVEY J M D | Chairman & CEO | 11/19/2014 | 76,853 |
Schlesinger Sarah J. | Director | 11/12/2014 | 8,086 |
Schlesinger Sarah J. | Director | 11/11/2014 | 8,190 |
BERGER HARVEY J M D | Chairman & CEO | 10/16/2014 | 67,317 |
BERGER HARVEY J M D | Chairman & CEO | 10/15/2014 | 63,727 |
Schlesinger Sarah J. | Director | 10/15/2014 | 6,539 |
Schlesinger Sarah J. | Director | 10/14/2014 | 6,591 |
BERGER HARVEY J M D | Chairman & CEO | 09/03/2014 | 78,859 |
BERGER HARVEY J M D | Chairman & CEO | 09/02/2014 | 77,777 |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | 09/09/2014 | 40,929 |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | 09/09/2014 | 40,925 |
BERGER HARVEY J M D | Chairman & CEO | 09/09/2014 | 716,525 |
BERGER HARVEY J M D | Chairman & CEO | 09/09/2014 | 784,500 |
BERGER HARVEY J M D | Chairman & CEO | 09/03/2014 | 78,859 |
BERGER HARVEY J M D | Chairman & CEO | 09/02/2014 | 77,777 |
Schlesinger Sarah J. | Director | 08/13/2014 | 7,423 |
Schlesinger Sarah J. | Director | 08/12/2014 | 7,176 |
Schlesinger Sarah J. | Director | 09/10/2014 | 7,475 |
Schlesinger Sarah J. | Director | 09/09/2014 | 7,709 |
FITZGERALD EDWARD M | Executive VP, CFO | 09/02/2014 | 261,500 |
FITZGERALD EDWARD M | Executive VP, CFO | 09/02/2014 | 310,835 |
Cantor Maria E | SVP, Corporate Affairs and HR | 09/02/2014 | 16,753 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/02/2014 | 34,125 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/02/2014 | 352,227 |
DENNER ALEXANDER J | Director | 08/15/2014 | 3,588,167 |
DENNER ALEXANDER J | Director | 08/15/2014 | 1,367,333 |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | 07/15/2014 | 14,527 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 07/15/2014 | 14,527 |
Cantor Maria E | SVP, Corporate Affairs and HR | 07/15/2014 | 14,527 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/15/2014 | 25,421 |
Haluska Frank | SVP, Clinical R&D, CMO | 07/15/2014 | 14,527 |
FITZGERALD EDWARD M | Executive VP, CFO | 07/15/2014 | 25,421 |
BERGER HARVEY J M D | Chairman & CEO | 07/15/2014 | 86,647 |
Duvall Martin J | EVP, CCO | 07/15/2014 | 5,085 |
Cantor Maria E | SVP, Corporate Affairs and HR | 06/02/2014 | 25,611 |
Haluska Frank | SVP, Clinical R&D, CMO | 04/02/2014 | 27,916 |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | 04/02/2014 | 19,718 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 04/02/2014 | 19,720 |
FITZGERALD EDWARD M | Executive VP, CFO | 04/01/2014 | 36,108 |
BERGER HARVEY J M D | Chairman & CEO | 04/01/2014 | 115,736 |
Cantor Maria E | SVP, Corporate Affairs and HR | 04/02/2014 | 34,907 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/02/2014 | 53,337 |
Cantor Maria E | SVP, Corporate Affairs and HR | 03/19/2014 | 16,880 |
Cantor Maria E | SVP, Corporate Affairs and HR | 03/21/2014 | 28,930 |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | 03/19/2014 | 12,334 |
BERSTEIN DAVID L | SVP, GC and Chief IP Officer | 03/21/2014 | 12,630 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/19/2014 | 16,880 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/21/2014 | 18,941 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/19/2014 | 20,770 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/21/2014 | 18,936 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/19/2014 | 28,190 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/21/2014 | 52,583 |
Duvall Martin J | EVP, CCO | 03/20/2014 | 4,301 |
Duvall Martin J | EVP, CCO | 03/19/2014 | 21,441 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/19/2014 | 28,133 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/20/2014 | 22,089 |
BERGER HARVEY J M D | Chairman & CEO | 03/20/2014 | 90,113 |
BERGER HARVEY J M D | Chairman & CEO | 03/19/2014 | 95,913 |
CLACKSON TIMOTHY P | President, R&D, CSO | 12/19/2013 | 50,115 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 12/19/2013 | 18,528 |
Cantor Maria E | SVP, Corporate Affairs | 12/19/2013 | 32,767 |
BERGER HARVEY J M D | Chairman & CEO | 12/18/2013 | 146,910 |
Haluska Frank | SVP, Clinical R&D, CMO | 12/19/2013 | 26,214 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 12/19/2013 | 23,130 |
Duvall Martin J | SVP, Commercial Operations | 09/19/2013 | 234,628 |
CLACKSON TIMOTHY P | President, R&D, CSO | 09/06/2013 | 185,878 |
FITZGERALD EDWARD M | Executive VP, CFO | 08/15/2013 | 350,284 |
FITZGERALD EDWARD M | Executive VP, CFO | 08/15/2013 | 128,700 |
BERGER HARVEY J M D | Chairman & CEO | 08/13/2013 | 905,555 |
BERGER HARVEY J M D | Chairman & CEO | 08/14/2013 | 57,999 |
BERGER HARVEY J M D | Chairman & CEO | 08/14/2013 | 1,164,335 |
BERGER HARVEY J M D | Chairman & CEO | 08/13/2013 | 49,570 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 07/18/2013 | 126,639 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 07/18/2013 | 158,290 |
Haluska Frank | SVP, Clinical R&D, CMO | 07/18/2013 | 126,642 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 07/18/2013 | 126,655 |
Keane Raymond T | SVP General Counsel & CCO | 07/18/2013 | 158,286 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/18/2013 | 277,045 |
Cantor Maria E | SVP, Corporate Affairs | 07/18/2013 | 158,299 |
BERGER HARVEY J M D | Chairman & CEO | 07/17/2013 | 52,912 |
BERGER HARVEY J M D | Chairman & CEO | 07/17/2013 | 980,705 |
BERGER HARVEY J M D | Chairman & CEO | 07/16/2013 | 56,623 |
BERGER HARVEY J M D | Chairman & CEO | 07/16/2013 | 2,866,478 |
BERGER HARVEY J M D | Chairman & CEO | 07/15/2013 | 729,600 |
FITZGERALD EDWARD M | Executive VP, CFO | 07/15/2013 | 277,565 |
BERGER HARVEY J M D | Chairman & CEO | 06/19/2013 | 104,415 |
BERGER HARVEY J M D | Chairman & CEO | 06/19/2013 | 97,208 |
BERGER HARVEY J M D | Chairman & CEO | 05/15/2013 | 48,983 |
BERGER HARVEY J M D | Chairman & CEO | 05/15/2013 | 675,970 |
BERGER HARVEY J M D | Chairman & CEO | 05/14/2013 | 48,600 |
BERGER HARVEY J M D | Chairman & CEO | 05/14/2013 | 900,295 |
BERGER HARVEY J M D | Chairman & CEO | 04/17/2013 | 97,201 |
BERGER HARVEY J M D | Chairman & CEO | 04/17/2013 | 1,800,590 |
Keane Raymond T | SVP General Counsel & CCO | 04/02/2013 | 46,625 |
Haluska Frank | SVP, Clinical R&D, CMO | 04/02/2013 | 61,339 |
Cantor Maria E | SVP, Corporate Affairs | 04/02/2013 | 76,665 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/02/2013 | 117,245 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 04/02/2013 | 43,295 |
BERGER HARVEY J M D | Chairman & CEO | 04/01/2013 | 360,290 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 04/02/2013 | 43,322 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/26/2013 | 242,492 |
Keane Raymond T | SVP General Counsel & CCO | 03/25/2013 | 248,482 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 03/25/2013 | 153,482 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/25/2013 | 198,807 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/25/2013 | 100,672 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/25/2013 | 361,766 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/25/2013 | 244,079 |
Cantor Maria E | SVP, Corporate Affairs | 03/22/2013 | 113,896 |
BERGER HARVEY J M D | Chairman & CEO | 03/22/2013 | 894,348 |
BERGER HARVEY J M D | Chairman & CEO | 03/20/2013 | 328,529 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/20/2013 | 55,665 |
Duvall Martin J | SVP, Commercial Operations | 03/22/2013 | 11,249 |
Keane Raymond T | SVP General Counsel & CCO | 03/22/2013 | 45,423 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 03/22/2013 | 46,698 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/22/2013 | 46,694 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/22/2013 | 46,694 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/22/2013 | 31,135 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/22/2013 | 129,718 |
Cantor Maria E | SVP, Corporate Affairs | 03/22/2013 | 71,335 |
BERGER HARVEY J M D | Chairman & CEO | 03/13/2013 | 1,102,990 |
BERGER HARVEY J M D | Chairman & CEO | 03/13/2013 | 59,587 |
BERGER HARVEY J M D | Chairman & CEO | 03/12/2013 | 1,101,755 |
BERGER HARVEY J M D | Chairman & CEO | 03/12/2013 | 59,516 |
Cantor Maria E | SVP, Corporate Affairs | 03/12/2013 | 46,310 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/04/2013 | 206,598 |
CLACKSON TIMOTHY P | President, R&D, CSO | 01/15/2013 | 292,414 |
FITZGERALD EDWARD M | Executive VP, CFO | 01/02/2013 | 501,890 |
LAVIDAS ATHANESE | Director | 12/21/2012 | 213,209 |
CLACKSON TIMOTHY P | President, R&D, CSO | 12/20/2012 | 141,210 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 12/18/2012 | 75,836 |
Cantor Maria E | SVP, Corporate Affairs | 12/18/2012 | 107,438 |
CLACKSON TIMOTHY P | President, R&D, CSO | 12/18/2012 | 164,306 |
FITZGERALD EDWARD M | Executive VP, CFO | 12/18/2012 | 164,306 |
Haluska Frank | SVP, Clinical R&D, CMO | 12/18/2012 | 107,438 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 12/18/2012 | 75,836 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 12/18/2012 | 75,836 |
BERGER HARVEY J M D | Chairman & CEO | 12/18/2012 | 526,577 |
Keane Raymond T | SVP General Counsel & CCO | 12/18/2012 | 65,302 |
LAMARCHE JAY R | Director | 10/01/2012 | 249,932 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 10/01/2012 | 9,750 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 10/01/2012 | 187,500 |
FITZGERALD EDWARD M | Executive VP, CFO | 10/01/2012 | 604,187 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/19/2012 | 9,750 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/19/2012 | 180,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/19/2012 | 59,491 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/19/2012 | 465,000 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/11/2012 | 9,750 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 09/11/2012 | 172,500 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/11/2012 | 59,491 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/11/2012 | 445,625 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/11/2012 | 59,491 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/11/2012 | 445,625 |
LAMARCHE JAY R | Director | 09/06/2012 | 39,900 |
LAMARCHE JAY R | Director | 09/06/2012 | 39,900 |
Keane Raymond T | SVP General Counsel & CCO | 09/06/2012 | 23,900 |
Keane Raymond T | SVP General Counsel & CCO | 09/06/2012 | 220,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/06/2012 | 59,491 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/06/2012 | 426,250 |
Keane Raymond T | SVP General Counsel & CCO | 09/04/2012 | 163,380 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/04/2012 | 42,102 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 09/04/2012 | 337,050 |
CLACKSON TIMOTHY P | President, R&D, CSO | 08/30/2012 | 32,503 |
LAMARCHE JAY R | Director | 08/15/2012 | 400,032 |
Keane Raymond T | SVP General Counsel & CCO | 08/15/2012 | 23,900 |
Keane Raymond T | SVP General Counsel & CCO | 08/15/2012 | 200,000 |
CLACKSON TIMOTHY P | President, R&D, CSO | 08/15/2012 | 278,533 |
CLACKSON TIMOTHY P | President, R&D, CSO | 08/15/2012 | 736,860 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 08/15/2012 | 160,000 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 07/30/2012 | 137,250 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 07/30/2012 | 543,400 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 07/30/2012 | 152,000 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/30/2012 | 121,514 |
CLACKSON TIMOTHY P | President, R&D, CSO | 07/30/2012 | 441,446 |
Keane Raymond T | SVP General Counsel & CCO | 07/30/2012 | 190,000 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 07/30/2012 | 9,750 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 07/30/2012 | 142,500 |
Cantor Maria E | SVP, Corporate Affairs | 07/30/2012 | 50,658 |
Cantor Maria E | SVP, Corporate Affairs | 07/30/2012 | 123,082 |
Keane Raymond T | SVP General Counsel & CCO | 07/26/2012 | 23,900 |
Keane Raymond T | SVP General Counsel & CCO | 07/26/2012 | 180,000 |
LAVIDAS ATHANESE | Director | 07/20/2012 | 89,977 |
FITZGERALD EDWARD M | Executive VP, CFO | 07/02/2012 | 440,950 |
Cantor Maria E | SVP, Corporate Affairs | 06/25/2012 | 30,199 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 06/22/2012 | 9,750 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 06/22/2012 | 131,269 |
LAVIDAS ATHANESE | Director | 06/20/2012 | 87,028 |
Cantor Maria E | SVP, Corporate Affairs | 06/19/2012 | 23,100 |
Cantor Maria E | SVP, Corporate Affairs | 06/19/2012 | 135,000 |
BERGER HARVEY J M D | Chairman & CEO | 06/13/2012 | 99,984 |
BERGER HARVEY J M D | Chairman & CEO | 06/13/2012 | 99,999 |
LAVIDAS ATHANESE | Director | 06/05/2012 | 159,750 |
LAVIDAS ATHANESE | Director | 06/05/2012 | 401,280 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 05/21/2012 | 109,254 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/26/2012 | 128,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 05/21/2012 | 431,398 |
LAVIDAS ATHANESE | Director | 05/21/2012 | 82,690 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 05/16/2012 | 387,275 |
FITZGERALD EDWARD M | Executive VP, CFO | 05/03/2012 | 277,800 |
CLACKSON TIMOTHY P | President, R&D, CSO | 05/02/2012 | 148,800 |
CLACKSON TIMOTHY P | President, R&D, CSO | 05/02/2012 | 340,000 |
Haluska Frank | SVP, Clinical R&D, CMO | 05/02/2012 | 7,170 |
Haluska Frank | SVP, Clinical R&D, CMO | 05/02/2012 | 51,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 05/02/2012 | 47,661 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 05/02/2012 | 329,375 |
LAVIDAS ATHANESE | Director | 04/20/2012 | 150,558 |
FITZGERALD EDWARD M | Executive VP, CFO | 04/17/2012 | 185,200 |
FITZGERALD EDWARD M | Executive VP, CFO | 04/17/2012 | 600,000 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/17/2012 | 106,665 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/13/2012 | 468,628 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 04/12/2012 | 262,576 |
LAVIDAS ATHANESE | Director | 04/09/2012 | 236,350 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 04/02/2012 | 83,416 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 04/02/2012 | 171,887 |
Cantor Maria E | SVP, Corporate Affairs | 04/03/2012 | 55,027 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/03/2012 | 84,134 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/26/2012 | 425,876 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 04/03/2012 | 38,844 |
Keane Raymond T | SVP General Counsel & CCO | 04/03/2012 | 33,455 |
FITZGERALD EDWARD M | Executive VP, CFO | 04/03/2012 | 84,156 |
BERGER HARVEY J M D | Chairman & CEO | 04/02/2012 | 282,337 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 04/02/2012 | 30,918 |
Haluska Frank | SVP, Clinical R&D, CMO | 04/03/2012 | 68,767 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 04/03/2012 | 38,836 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/26/2012 | 47,925 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/26/2012 | 120,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/26/2012 | 47,661 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/26/2012 | 182,000 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 03/26/2012 | 137,250 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 03/26/2012 | 412,500 |
Cantor Maria E | SVP, Corporate Affairs | 03/26/2012 | 18,480 |
Cantor Maria E | SVP, Corporate Affairs | 03/27/2012 | 292,138 |
Cantor Maria E | SVP, Corporate Affairs | 03/26/2012 | 96,000 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/26/2012 | 7,170 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/26/2012 | 48,000 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/23/2012 | 102,718 |
Keane Raymond T | SVP General Counsel & CCO | 03/23/2012 | 162,271 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 03/23/2012 | 380,712 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/23/2012 | 199,239 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/22/2012 | 162,178 |
BERGER HARVEY J M D | Chairman & CEO | 03/22/2012 | 639,368 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/23/2012 | 236,211 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/23/2012 | 162,274 |
BERGER HARVEY J M D | Chairman & CEO | 03/20/2012 | 157,092 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/20/2012 | 282,314 |
Keane Raymond T | SVP General Counsel & CCO | 03/20/2012 | 126,155 |
Haluska Frank | SVP, Clinical R&D, CMO | 03/20/2012 | 225,240 |
FITZGERALD EDWARD M | Executive VP, CFO | 03/20/2012 | 468,605 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 03/20/2012 | 194,799 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/20/2012 | 546,622 |
Cantor Maria E | SVP, Corporate Affairs | 03/20/2012 | 210,218 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/16/2012 | 62,192 |
BERGER HARVEY J M D | Chairman & CEO | 03/10/2012 | 998,660 |
LAMARCHE JAY R | Director | 02/28/2012 | 88,800 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 02/28/2012 | 44,703 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 02/28/2012 | 176,313 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 02/23/2012 | 137,250 |
DODION PIERRE F | SVP, Corp. Dev. & Operations | 02/23/2012 | 375,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 02/23/2012 | 61,500 |
Haluska Frank | SVP, Clinical R&D, CMO | 02/21/2012 | 10,755 |
Haluska Frank | SVP, Clinical R&D, CMO | 02/21/2012 | 65,277 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 02/21/2012 | 88,920 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 02/21/2012 | 509,032 |
BERGER HARVEY J M D | Chairman & CEO | 02/15/2012 | 344,826 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/14/2012 | 64,350 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/14/2012 | 255,750 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/14/2012 | 312,908 |
CLACKSON TIMOTHY P | President, R&D, CSO | 02/14/2012 | 1,155,781 |
Keane Raymond T | SVP General Counsel & CCO | 02/14/2012 | 16,250 |
Keane Raymond T | SVP General Counsel & CCO | 02/14/2012 | 189,178 |
LAMARCHE JAY R | Director | 01/27/2012 | 404,974 |
LAMARCHE JAY R | Director | 01/26/2012 | 46,627 |
BERGER HARVEY J M D | Chairman & CEO | 07/26/2011 | 100,018 |
CLACKSON TIMOTHY P | President, R&D, CSO | 06/07/2011 | 378,576 |
CLACKSON TIMOTHY P | President, R&D, CSO | 06/07/2011 | 339,000 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 06/07/2011 | 381,854 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 06/07/2011 | 339,000 |
LAMARCHE JAY R | Director | 05/09/2011 | 141,241 |
LAMARCHE JAY R | Director | 05/09/2011 | 141,250 |
DODION PIERRE F | Senior VP, Corp. Development | 04/11/2011 | 61,599 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 04/11/2011 | 123,190 |
CLACKSON TIMOTHY P | President, R&D, CSO | 04/11/2011 | 103,123 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 04/11/2011 | 54,204 |
FITZGERALD EDWARD M | Executive VP, CFO | 04/11/2011 | 78,120 |
LAMARCHE JAY R | Director | 03/25/2011 | 175,277 |
Keane Raymond T | SVP General Counsel & CCO | 03/22/2011 | 54,660 |
Haluska Frank | VP, Clinical R&D, CMO | 03/22/2011 | 28,116 |
DODION PIERRE F | Senior VP, Corp. Development | 03/22/2011 | 42,276 |
CLACKSON TIMOTHY P | President, R&D, CSO | 03/22/2011 | 78,424 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 03/22/2011 | 66,769 |
BERSTEIN DAVID L | Senior VP, Chief IP Officer | 03/22/2011 | 54,373 |
LAMARCHE JAY R | Director | 02/02/2011 | 161,925 |
LAMARCHE JAY R | Director | 01/11/2011 | 137,675 |
LAMARCHE JAY R | Director | 01/11/2011 | 137,388 |
LAMARCHE JAY R | Director | 12/20/2010 | 125,006 |
Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 10/26/2010 | 11,100 |
CLACKSON TIMOTHY P | Pres., R & D., Chief Sci. Off. | 10/26/2010 | 37,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...